India’s first indigenously developed anti-malarial drug Synriam is India’s first indigenously developed anti-malarial drug. It beats all currently available options on the counts of affordability, compliance and relief. The drug is the result of first successful public-private partnership on pharmaceutical research and development in India. Ranbaxy and the Ministry ofContinue Reading